Have a question? Want more information? We are happy to answer your questions.
The 2013 recommended childhood and adolescent vaccine schedules have been revised.
GlaxoSmithKline (GSK) has started offering up front pricing to members who meet certain performance requirements.
Beginning March 1, 2013, GlaxoSmithKline (GSK) will accept and fulfill orders for the Menveo vaccine manufactured by Novartis.